Form D · Biotechnology
Kurin, Inc.
San Diego, CA · CIK 0001686805
Offering snapshot reported Aug 15, 2017 · SEC filing
- Reported sold
- $75K Offering amount: $6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2017 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Oct 7, 2016 | Initial | $2,322,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292847
Source: Form D, filed Aug 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eddie Rodriguez | Director |
| Bobby E. Rogers | Director, Executive |
| Terry Vandewarker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10755 Scripps Poway Parkway, No. 257
San Diego, CA, 92131
San Diego, CA, 92131